Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The role AIB1D4 cistrome in early breast cancer progression

ABSTRACT: The role AIB1D4 cistrome in early breast cancer progression

PROVIDER: PRJNA579385 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

The role of AIB1D4 cistrome in early breast cancer progression

Project description:The role of AIB1D4 cistrome in early breast cancer progression

| PRJNA604234 | ENA

AIB1D4 role in early breast cancer progression

Project description:AIB1D4 role in early breast cancer progression

| PRJNA578942 | ENA

AIB1D4 role in early breast cancer progression

Project description:We report the role of AIB1D4 in early stage breast cancer progression. Using CRISPR editing, we generated isogeneic cell lines that only express AIB1D4 and not full length AIB1 then extracted RNA for sequencing from cell lines and mamary fat pad xenografts in SCID/Beige mice. Data was aligned to Hg19 with STAR and processed with EdgeR.

2020-11-08 | GSE139270 | GEO

FOXM1 Cistrome Predicts Breast Cancer Metastatic Outcome Better Than FOXM1 Expression Levels or Tumor Proliferation Index [ChIP-Seq]

Project description:FOXM1 is a key transcription factor regulating cell cycle progression, DNA damage response, and a host of other hallmark cancer features, but the role of the FOXM1 cistrome in driving estrogen receptor-positive (ER+) vs. ER- breast cancer clinical outcomes remains undefined. Chromatin immunoprecipitation sequencing (ChIP-Seq) coupled with RNA sequencing (RNA-Seq) analyses was used to identify FOXM1 target genes in breast cancer cells (MCF-7) where FOXM1 expression was either induced by cell proliferation or repressed by p53 upregulation.

2015-10-26 | E-GEOD-72977 | biostudies-arrayexpress

FOXM1 Cistrome Predicts Breast Cancer Metastatic Outcome Better Than FOXM1 Expression Levels or Tumor Proliferation Index [RNA-Seq]

2015-10-26 | E-GEOD-73370 | biostudies-arrayexpress

FOXM1 Cistrome Predicts Breast Cancer Metastatic Outcome Better Than FOXM1 Expression Levels or Tumor Proliferation Index [RNA-Seq]

2015-10-26 | GSE73370 | GEO

FOXM1 Cistrome Predicts Breast Cancer Metastatic Outcome Better Than FOXM1 Expression Levels or Tumor Proliferation Index [ChIP-Seq]

2015-10-26 | GSE72977 | GEO

HOTAIR Modulated Pathways in Early-Stage Breast Cancer Progression

Project description:HOTAIR Modulated Pathways in Early-Stage Breast Cancer Progression

| PRJNA758976 | ENA

Regulatory cistrome landscape of Foxa1 and Foxa2 during prostate cancer progression [ChIP-seq]

Project description:To characterize the genome-wide regulatory cistrome of Foxa1 and Foxa2, we performed both Foxa1 and Foxa2 chromatin immunoprecipitation followed by sequencing (ChIP-seq) on freshly dissociated prostate tumor cells at the early stage (2 weeks post tamoxifen administration) and the late stage (6 months post tamoxifen administration) of NEPC progression, respectively.

2022-10-31 | GSE191182 | GEO

The role of UBE2T in breast cancer growth and progression

Project description:The role of UBE2T in breast cancer growth and progression

| PRJNA658487 | ENA